We provide 1 form of Cobimetinib
Cobimetinib
934660-93-2
|
531.063
|
5.264
Cobimetinib is an antineoplastic agent and selective inhibitor of the mitogen-activated extracellular kinase pathway used to treat unresectable or metastatic melanoma.
GDC-0973 | RG7420 | XL518 | [14C]-GDC-0973 | cobimetinib | cotellic
Cobimetinib is an antineoplastic agent and selective inhibitor of the mitogen-activated extracellular kinase pathway used to treat unresectable or metastatic melanoma.
GDC-0973 | RG7420 | XL518 | [14C]-GDC-0973 | cobimetinib | cotellic
$324/5 mg
(EBC)
1
We provide 0 compound for Cobimetinib